NCT00378222
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
Not specified
Clinical trial condition
Multiple Myeloma
Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.
2,606 public trials
492 recruiting studies
Multiple Myeloma trial results
NCT00367185
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Lille University Hospital Lille, France
Completed
A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma
NCT00096837
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
NCT00323505
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Royal Marsden NHS trust Sutton, Surrey, United Kingdom
NCT00301275
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Royal Marsden NHS trust Sutton, Surrey, United Kingdom
NCT00078065
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Oncotherapeutics Los Angeles, California, United States
- University of California, San Diego San Diego, California, United States
- University of California, San Francisco San Francisco, California, United States
- Johns Hopkins Medical Institute Baltimore, Maryland, United States
Completed
Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma
NCT00036140
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Research Center Los Angeles, California, United States
- Research Center Los Angeles, California, United States
- Research Center Rancho Mirage, California, United States
- Research Center Cleveland, Ohio, United States
Active, Not Recruiting
A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma
NCT03091257
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
Active, Not Recruiting
A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma
NCT07030517
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- M S Ramaiah Medical College and Hospital Bangalore, India
- St. Johns Medical College And Hospital Bengaluru, India
- Post Graduate Institute of Medical Education And Research PGIMER Chandigarh, India
- Bhagwan Mahaveer Cancer Hospital & Research Centre Jaipur, India
Active, Not Recruiting
Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
NCT00114101
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, DS Stage I Multiple Myeloma, +19 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- UC San Diego Medical Center - Hillcrest San Diego, California, United States